Adaptive Biotechnologies revenue was $85.07 m in FY, 2019
Adaptive Biotechnologies revenue breakdown by business segment: 59.2% from Sequencing revenue and 40.8% from Development revenue
|FY, 2018||FY, 2017|
|Sequencing revenue||32.98 m||22.76 m|
|Development revenue||22.69 m||15.69 m|
Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.